Effects of Integrase Inhibitor–Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV
Mabel Toribio(Boston College), Markella V. Zanni(Harvard University), Sarah M Chu(Harvard University), Gregory K. Robbins(Harvard University), Evelynne S. Fulda(Cancer Research And Biostatistics), Steven Grinspoon(Massachusetts General Hospital), Kathleen Melbourne(Gilead Sciences (United States)), Tricia H. Burdo(Temple University), Tomas G. Neilan(Albert Einstein College of Medicine), Meghan N. Feldpausch(Harvard University), Madeline Cetlin(Harvard University)
Cited by 11
Related Papers
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
|New England Journal of Medicine|2005|1.1k